CRL · Healthcare
What a holder would want to know before buying CRL: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.
Today’s price is 101% above the lowest point of the past year and 3% below the highest.
Over the past year it was cheaper than today on 99% of days and more expensive on 1%. Over the last 10 years: cheaper on 91% of days.
42% above its average price of the last 200 trading days.
Fell 20% or more 4 times in 10 years. The deepest fall was 78%; the longest took 6 months to get back to its peak. 3 of 4 have recovered so far.
It is in one now: 34% below the Sep 2021 peak.
Charles River Laboratories International, Inc. · Healthcare · Diagnostics & Research · a large company worth $14.54B
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research…
revenue profit
Sales of $4.02B in 2025, and a loss of $144.34M. Sales grew in 1 of the last 3 years.
Loses money on its sales at the moment.
Would need about 6.5 years of free cash flow to repay all its debt.
Not profitable over the last year. You pay $24 for every $1 of profit expected next year.
A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.
Pays no dividend.
18 analysts: 15 say buy, 2 hold, 1 sell. Their average 12-month target is $310.53 (range $145.00–$357.00).
Insiders made 0 purchases and 11 sales in the last 6 months. Executives routinely sell shares they were paid in; buying with their own money is the rarer signal.
Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.
Poshkan is paper trading: real prices, virtual money. Buy CRL with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.
Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.